The biotechnology beauty supply chain is moving from a niche sustainability discussion to a core strategic issue for cosmetics manufacturers, brand owners, importers, responsible persons and safety assessors. Cosmetics Business reports that the sector emits an estimated 50 million tonnes of CO2 annually, comparable to the emissions of Belgium alone. The same report highlights that fossil carbon-based ingredients are used in around 87% of formulations, making ingredient choices a central part of the industry’s climate footprint.
Climate debates have long focused on energy, transport and heavy industry. Beauty products rarely enter the conversation. Yet every moisturiser, shampoo, lipstick and serum depends on a global manufacturing system shaped by fossil-derived feedstocks, resource-intensive supply chains and single-use packaging.
As sustainability shifts from a marketing differentiator to a commercial imperative, the industry faces a difficult question: how can it continue to deliver performance, innovation and growth while reducing environmental impact? The answer, according to the source, increasingly lies in biology.
For the full context, see Cosmetics Business’s report on the biotechnology beauty supply chain.
Why the current beauty supply chain is under pressure
The cosmetics industry has a significant and often underestimated climate footprint. According to the source, the sector emits an estimated 50 million tonnes of CO2 annually, a figure comparable to Belgium’s total emissions. This is largely driven by a deep reliance on fossil carbon-based ingredients.
Those ingredients appear in around 87% of formulations. That dependence leaves the industry exposed to supply chain volatility, shifting consumer expectations and increasing pressure to demonstrate environmental progress. Single-use packaging and resource-intensive manufacturing add further strain.
Fossil-based materials are present in many product categories, from functional ingredients to those that influence texture and stability. Because these materials are embedded throughout formulations, reducing the overall footprint is not simply a packaging or transport challenge.
Many brands already talk about sustainability, but the underlying feedstock problem is not always visible in marketing narratives. A product can be positioned as natural or responsible while still relying on petrochemical inputs at the formulation level. That gap between perception and material reality is becoming harder to ignore.
The source argues that the sector can no longer treat climate performance as an afterthought. The question is not whether sustainability matters, but how companies can achieve it without sacrificing product quality, safety or commercial viability.
How the biotechnology beauty supply chain can reduce fossil dependence
Dr. Jen Vanderhoven, CEO of the Bio-based and Biodegradable Industries Association (BBIA), explains that biotechnology can help the beauty industry move towards materials that are sustainable, higher performing and more resilient. The source presents this shift as a way to address the environmental impact of formulations while maintaining innovation.
Rather than focusing only on packaging or distribution, the biotechnology beauty supply chain targets the start of the value chain: the raw materials used in cosmetic products. Bio-based production routes can offer alternatives to petrochemical feedstocks, reducing the carbon embedded in everyday formulations.
This is not a simple drop-in replacement exercise. It affects sourcing strategies, supplier qualification, manufacturing processes, product stability and performance testing. Businesses that understand the biotechnology beauty supply chain will be better positioned to manage reformulation projects and respond to incoming supply chain or regulatory pressure.
The BBIA perspective summarised in the article suggests that bio-based and biodegradable approaches can improve resilience, not only environmental performance. That is a significant point for cosmetics brands because it links sustainability to long-term supply security and product differentiation.
Another subtle but important point is resilience. A supply chain built on diverse, renewable feedstocks may be less exposed to price shocks or availability constraints than one dependent on a narrow set of petrochemical inputs. That has direct business value beyond sustainability reporting.
From fossil-derived feedstocks to bio-based materials
The source frames biotechnology as a strategic answer to the industry’s reliance on fossil carbon. Shifting towards bio-based materials can reduce the carbon footprint associated with raw ingredients while supporting new sources of performance and functionality.
Responsible persons and safety assessors should not treat this as only a sustainability project. Bio-based ingredient changes still require full technical and regulatory evaluation before they enter a formulation.
EU and UK compliance considerations for bio-based cosmetic ingredients
The article extract does not announce a specific EU or UK regulatory change. For compliance teams, however, the shift towards biotechnology-derived ingredients raises practical questions under existing cosmetic product requirements.
Cosmetic products placed on the EU and UK markets must be safe, properly assessed and supported by appropriate documentation. When a conventional fossil-based ingredient is replaced with a biotechnology-derived alternative, the responsible person must ensure that the safety assessment, documentation and labelling remain accurate and complete.
Raw material origin, purity, traceability and stability data form part of that assessment. A bio-based ingredient is not automatically exempt from normal safety or quality expectations simply because it is renewable or produced using biotechnology.
For safety assessors, the key question is whether the bio-based alternative introduces a different impurity profile, degradation behaviour or interaction with other ingredients. The same toxicological principles apply even when the starting material is renewable.
For brand owners and importers managing multiple formulations, this can be resource-intensive. EU and UK cosmetic compliance support can help manage safety documentation, responsible person duties and reformulation projects.
Green claims and evidence
The source indicates that sustainability is now a commercial imperative, not just a marketing angle. That means any environmental benefit communicated to buyers or consumers should be supported by evidence and consistent with applicable rules on advertising and consumer protection.
Bio-based does not automatically equal biodegradable, lower carbon or sustainable under all conditions. Regulatory and brand teams should define the specific benefit, test it where appropriate and retain documentation before making claims.
This is especially relevant for companies placing products in both the EU and the UK, where marketing claims may be reviewed under different national and regional frameworks. Even without a new rule in the source, the direction of travel points towards greater scrutiny of green claims and ingredient provenance.
Practical actions for cosmetics manufacturers and brand owners
Companies that view the biotechnology beauty supply chain as a strategic opportunity should start with a structured review rather than isolated ingredient swaps. The following actions can help manufacturers, importers and responsible persons manage the transition.
- Assess the proportion of fossil carbon-based ingredients in existing formulations and identify priority categories for reformulation.
- Request technical data from raw material suppliers on feedstock origin, production route, performance, stability and environmental fate.
- Update the cosmetic product safety report and product information file before introducing biotechnology-derived alternatives.
- Review sustainability claims against evidence and current EU and UK expectations for green claims substantiation.
- Involve safety assessors early when evaluating bio-based ingredients, especially where impurities, allergens or degradation products may differ from conventional materials.
- Monitor guidance from BBIA and other industry bodies on definitions, standards and best practice for bio-based and biodegradable materials.
These steps are not separate from regulatory compliance; they are part of it. Reformulation without documentation can create gaps in the product information file and increase the risk of non-compliant marketing claims.
What to monitor next
The full Cosmetics Business article is available to subscribers, and the extract points to a wider discussion about bio-based and biodegradable industries. Businesses should watch for further detail from BBIA on how biotechnology can be deployed across personal care value chains.
Procurement and innovation teams should monitor supplier capabilities and performance data for bio-based ingredients. Regulatory teams should watch for EU and UK developments on sustainability claims, packaging and bio-based content.
The source was published on 9 September 2026, so businesses may also want to track any follow-up commentary, conference presentations or standards updates that build on the arguments summarised in the article.
In practice, this means assigning clear responsibility for monitoring industry guidance and regulatory signals. The companies that act early will be better placed to evaluate bio-based alternatives and make informed decisions.
Conclusion
The biotechnology beauty supply chain is not a distant concept; it is becoming a practical framework for reducing fossil reliance while protecting performance and resilience. The source shows that cosmetics businesses must confront the climate footprint of their formulations, not just their packaging or logistics.
Bio-based ingredients are moving from niche to strategic. Document safety, evidence and supplier data before reformulating.